Ganglioside GD2 in small cell lung cancer cell lines: Enhancement of cell proliferation and mediation of apoptosis

Cancer Research

Volumn 61, Issue 10, 2001, Pages 4244-4252

  Yoshida, Shoko ^a,b   Fukumoto, Satoshi ^a,c   Kawaguchi, Haruhiko ^b   Sato, Shigeki ^b   Ueda, Ryuzo ^b   Furukawa, Koichi ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^c NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE GD2; GLYCOSYLTRANSFERASE; MONOCLONAL ANTIBODY;

ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL DEATH; CELL KILLING; CELL PROLIFERATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUNG SMALL CELL CANCER; PHENOTYPE; PRIORITY JOURNAL; TRANSACTIVATION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ANTIBODIES, MONOCLONAL; APOPTOSIS; CARBOHYDRATE SEQUENCE; CARCINOMA, SMALL CELL; CELL DIVISION; DNA, COMPLEMENTARY; FLOW CYTOMETRY; G(M1) GANGLIOSIDE; G(M2) GANGLIOSIDE; GANGLIOSIDES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MOLECULAR SEQUENCE DATA; N-ACETYLGALACTOSAMINYLTRANSFERASES; PHENOTYPE; SIALYLTRANSFERASES; TRANSFECTION; UP-REGULATION;

EID: 0035872467     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Bifunctional role of glycosphingolipids. Modulators for transmembrane signaling and mediators for cellular interactions
2. Gangliosides of human melanoma
3. Ganglioside expression on human malignant melanoma assessed by quantitative immune thin-layer chromatography
4. Expression of disialogangliosides GD2 and GD3 on human soft tissue sarcomas
5. Ganglioside composition and its relation to clinical data in brain tumors
6. Selection of tumor antigens as targets for immune attack using immunohistochemistry. II. Blood group-related antigens
7. Gangliosides in melanoma
8. Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: A Phase I trial in patients with malignant melanoma
9. Monoclonal antibodies to a glycolipid antigen on human neuroblastoma cells
10. D2 ganglioside can eradicate syngeneic cancer micrometastases
11. Enhancement of in vitro and in vivo antitumor activity of anti-GD2 monoclonal antibody 220-51 against human neuroblastoma by granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor
12. D2 on human neuroblastoma cells: Target antigen for monoclonal antibody-mediated cytolysis and suppression of tumor growth
13. tax
14. Inhibition of human melanoma cell growth in vitro by monoclonal anti-GD3-ganglioside antibody
15. Human melanoma cell lines deficient in GD3 ganglioside expression exhibit altered growth and tumorigenic characteristics
16. Blood vessel invasion and expression of sialyl Lewisx and proliferating cell nuclear antigen in stage 1 non-small cell lung cancer. Relation to postoperative recurrence
17. Establishment of monoclonal antibodies specific for ganglioside GM1: Detection of ganglioside GM1 in small cell lung carcinoma cell lines and tissues
18. Binding specificity of monoclonal antibodies to ganglioside, Fuc-GM1
19. Monoclonal antibodies for diagnosis and potential therapy of small cell lung cancer-the ganglioside antigen fucosyl-GM1
20. Reactivity of monoclonal antibodies with ganglioside antigens in human small cell lung cancer tissues
21. Ganglioside expression in lung cancer cell lines
22. D2, a relevant target antigen on small cell lung carcinoma for monoclonal antibody-mediated cytolysis
23. M1-keyhole limpet hemocyanin conjugate vaccine in patients with small cell lung cancer
24. Antiganglioside GM2 monoclonal antibody-dependent killing of human lung cancer cells by lymphocytes and monocytes
25. Therapeutic efficacy of mouse-human chimeric antiganglioside GM2 monoclonal antibody against multiple organ micrometastases of human lung cancer in NK cell-depleted SCID mice
26. Targeting of small-cell lung cancer using the anti-GD2 ganglioside monoclonal antibody 3F8: A pilot trial
27. Expression cloning of rat cDNA encoding UDP-galactose: GD2 βI,3-galactosyltransferase that determines the expression of GDIβ/GMI/GAI
28. Isolation of GD3 synthase gene by expression cloning of GM3 α-2,8-sialyltransferase cDNA using anti-GD2 monoclonal antibody
29. Expression cloning of β1,4-N-acetylgalactosaminyltransferase cDNAs that determine the expression of GM2 and GD2 gangliosides
30. Analysis of the specificity of five murine antiblood group A monoclonal antibodies, including one that identifies type 3 and type 4 A determinants
31. Protein measurement with the Folin phenol reagent
32. Molecular cloning of globotriaosylceramide/CD77 synthase, a glycosyltransferase that initiates the synthesis of globo series glycosphingolipids
33. In vitro invasion of small-cell lung cancer cell lines correlates with expression of epidermal growth factor receptor
34. Essential roles of carbohydrate signals in development, immune response, and tissue functions, as revealed by gene targeting
35. Induction of cholinergic differentiation with neurite sprouting by de novo biosynthesis and expression of GD3 and β-series gangliosides in Neuro2α cells
36. GD3 synthase gene expression in PC12 cells results in the continuous activation of TrkA and ERK1/2 and enhanced proliferation
37. Myelination in the absence of galactocerebroside and sulfatide: Normal structure with abnormal function and regional instability
38. Requirement of seminolipid in spermatogenesis revealed by UDP-galactose: Ceramide galactosyltransferase-deficient mice
39. Mice with disrupted GM2/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system
40. Complex gangliosides are essential in spermatogenesis of mice: Possible roles in the transport of testosterone
41. Attenuation of interleukin 2 signal in the spleen cells of complex ganglioside-lacking mice
42. D2 ganglioside biosynthesis is a distinct biochemical event in human melanoma tumor progression
43. Inhibition of metastases of a human melanoma xenograft by monoclonal antibody to the GD2/GD3 gangliosides
44. Disialogangliosides GD2 and GD3 are involved in the attachment of human melanoma and neuroblastoma cells to extracellular matrix proteins
45. Human melanoma antigen AH is an autoantigenic ganglioside related to GD2
46. Identification of a human neuroectodermal tumor antigen (OFA-I-2) as ganglioside GD2
47. 3F8 monoclonal antibody treatment of patients with stage 4 neuroblastoma: A Phase II study
48. D3 in rat brain. Possible regulation of Lyn by glycosphingolipid in caveolae-like domains
49. Apoptosis induction of human lung cancer cell line in multicellular heterospheroids with humanized antiganglioside GM2 monoclonal antibody
50. D2 antibody therapy in children with neuroblastoma: A report of a series
51. Chromatographic separation of human brain gangliosides